Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2022-02-14
Product name:
INTELLI-DESVENLAFAXINE
DIN:
02469847
Product Monograph/Veterinary Labelling:
Date:
2024-06-24
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
INTELLIPHARMACEUTICS CORP
30 Worcester Road
Toronto
Ontario
Canada
M9W 5X2
Class:
Human
Dosage form(s):
Tablet (Extended-Release)
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
28:16.04.16
Anatomical Therapeutic Chemical (ATC): See footnote 4
N06AX23 DESVENLAFAXINE
Active ingredient group (AIG) number:See footnote5
0152509001
| Active ingredient(s) | Strength |
|---|---|
| DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) | 50 MG |